Kartal Dr Lutfi Kirdar Tranining and Research Hospital
Istanbul, 34890, Turkey (Türkiye)
NCT Number: NCT04455945
Following colorectal surgery, many patients face a combination of physical and emotional problems for a long period of time. Symptoms such as pain, fatigue, and disturbed bowel and sexual function, as well as problems in social and role functioning, inevitably affect the patients' well-being. Therefore, evaluation of the self-reported quality of life (QoL) is becoming increasingly important in clinical trials. The investigators aimed to compare long term health related life quality (HRQoL) results of laparoscopic approach with open approach in patients with sphincter preserving resections for rectal cancer at a single-center.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Istanbul, 34890, Turkey (Türkiye)
This study is planned prospectively. All patients scheduled for operation due to rectal cancer in our clinic between January 2017 and December 2018 will be evaluated for suitability for the study. During the preoperative examination, patients will be informed about the study and their written consent will be obtained. Patients will be randomized between open and laparoscopic groups in the ratio 2:1, depending on the type of surgery. Clinical data of patients will be analyzed from the hospital database programme.
The EORTC QLQ-C30 and QLQ-CR29 questionnaires prepared by The European Organization for Research and Treatment of Cancer (EORTC) will be used to evaluate the quality of life after the operation. The EORTC QLQ-C30 questionnaire will be completed by examining the patients' daily observation notes. EORTC QLQ-CR29 will be completed with face to face interviews in the first year after surgery.
In this way, it will be aimed to compare the early and long-term quality of life (HRQoL) results of open and laparoscopic approach in patients undergoing surgery for rectal cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Open sphincter preserving surgery for rectal cancer
Laparoscopic sphincter preserving surgery for rectal cancer
Time frame: Before surgery
Years
Time frame: Before surgery
Male/Female
Time frame: Before surgery
kg/m²
Time frame: Before surgery
I, II, III, IV
Time frame: During the operation
Upper/Middle/Low
Time frame: up to 10 days after surgery
1A, 1B, 2A, 2B, 3A, 3B, 3C
Time frame: Through study completion, an average of 1 year
yes/no
Time frame: During one week after surgery
Global/Physical/Role/Cognitive/Social functioning. All scales and single-item measurements range from 0 to 100. A higher score on a functional scale indicates better functioning.
Time frame: During one week after surgery
Fatigue/Nausea and vomiting/Pain/Dyspnoea/Insomnia/Appetite loss/Constipation/Diarrhoea/Financial difficulties. All scales and single-item measurements range from 0 to 100. A higher score for a symptom scale / item indicates a higher symptomatology and problem level.
Time frame: During one year after surgery
Body Image/Future projections/Weight/Sexual interest. All scales and single-item measurements range from 0 to 100. A higher score on a functional scale indicates better functioning.
Time frame: During one year after surgery
Urinary frequency/Blood and mucus in stool/Stool frequency/Urinary incontinence/Dysuria/Abdominal pain/Buttock pain/Bloating/Dry mouth/Hair loss/Taste/Flatulence/Faecal incontinence/Sore skin/Embarrassment/Impotence/Dyspareunia. All scales and single-item measurements range from 0 to 100. A higher score for a symptom scale / item indicates a higher symptomatology and problem level.
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Other Gov
Comparison of Quality of Life Outcomes Between Laparoscopic and Open Approach for Rectal Cancer Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06505863
Colorectal Neoplasms, Digestive System Diseases
Sankt Gallen, Canton of St. Gallen, Switzerland
View Trial DetailsNCT06758830
Chemoradiotherapy, Chemotherapy
Vilnius, Lithuania
View Trial DetailsNCT04075305
Bladder Cancer, Bladder Neoplasm
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06087718
Brachytherapy, Colorectal Neoplasms
Maastricht, Limburg, Netherlands
View Trial Details